Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 349
Filter
1.
PLoS Negl Trop Dis ; 18(6): e0012242, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38900786

ABSTRACT

BACKGROUND: In Southeast Asia, treatment is recommended for all patients with post-kala-azar dermal leishmaniasis (PKDL). Adherence to the first-line regimen, twelve weeks of miltefosine (MF), is low and ocular toxicity has been observed with this exposure period. We assessed the safety and efficacy of two shorter-course treatments: liposomal amphotericin B (LAmB) alone and combined with MF. METHODOLOGY/PRINCIPAL FINDINGS: An open-label, phase II, randomized, parallel-arm, non-comparative trial was conducted in patients with parasitologically confirmed PKDL, 6 to ≤60 years. Patients were assigned to 20 mg/kg LAmB (total dose, in five injections over 15 days) alone or combined with allometric MF (3 weeks). The primary endpoint was definitive cure at 12 months, defined as complete resolution of papular and nodular lesions and >80% re-pigmentation of macular lesions. Definitive cure at 24 months was a secondary efficacy endpoint. 118/126 patients completed the trial. Definitive cure at 12 months was observed in 29% (18/63) patients receiving LAmB and 30% (19/63) receiving LAmB/MF (mITT), increasing to 58% and 66%, respectively, at 24 months. Most lesions had resolved/improved at 12 and 24 months for patients receiving LAmB (90%, 83%) and LAmB/MF (85%, 88%) by qualitative assessment. One death, unrelated to study drugs, was reported; no study drug-related serious adverse events were observed. The most frequent adverse drug reactions were MF-related vomiting and nausea, and LAmB-related hypokalaemia and infusion reactions. Most adverse events were mild; no ocular adverse events occurred. CONCLUSIONS/SIGNIFICANCE: Both regimens are suitably safe and efficacious alternatives to long-course MF for PKDL in South Asia. TRIAL REGISTRATION: CTRI/2017/04/008421.


Subject(s)
Amphotericin B , Antiprotozoal Agents , Leishmaniasis, Cutaneous , Leishmaniasis, Visceral , Phosphorylcholine , Humans , Amphotericin B/therapeutic use , Amphotericin B/adverse effects , Amphotericin B/administration & dosage , Phosphorylcholine/analogs & derivatives , Phosphorylcholine/therapeutic use , Phosphorylcholine/administration & dosage , Phosphorylcholine/adverse effects , Bangladesh , Male , Antiprotozoal Agents/therapeutic use , Antiprotozoal Agents/adverse effects , Antiprotozoal Agents/administration & dosage , Adult , Adolescent , Female , Middle Aged , Young Adult , Child , India , Leishmaniasis, Visceral/drug therapy , Treatment Outcome , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/parasitology , Drug Therapy, Combination
2.
Development ; 151(11)2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38752444

ABSTRACT

Stem cell homeostasis in the shoot apical meristem involves a core regulatory feedback loop between the signalling peptide CLAVATA3 (CLV3), produced in stem cells, and the transcription factor WUSCHEL, expressed in the underlying organising centre. clv3 mutant meristems display massive overgrowth, which is thought to be caused by stem cell overproliferation, although it is unknown how uncontrolled stem cell divisions lead to this altered morphology. Here, we reveal local buckling defects in mutant meristems, and use analytical models to show how mechanical properties and growth rates may contribute to the phenotype. Indeed, clv3 mutant meristems are mechanically more heterogeneous than the wild type, and also display regional growth heterogeneities. Furthermore, stereotypical wild-type meristem organisation, in which cells simultaneously express distinct fate markers, is lost in mutants. Finally, cells in mutant meristems are auxin responsive, suggesting that they are functionally distinguishable from wild-type stem cells. Thus, all benchmarks show that clv3 mutant meristem cells are different from wild-type stem cells, suggesting that overgrowth is caused by the disruption of a more complex regulatory framework that maintains distinct genetic and functional domains in the meristem.


Subject(s)
Arabidopsis Proteins , Arabidopsis , Indoleacetic Acids , Meristem , Mutation , Plant Shoots , Stem Cells , Arabidopsis/genetics , Arabidopsis/growth & development , Arabidopsis/metabolism , Arabidopsis Proteins/metabolism , Arabidopsis Proteins/genetics , Meristem/metabolism , Meristem/cytology , Meristem/growth & development , Meristem/genetics , Mutation/genetics , Stem Cells/metabolism , Stem Cells/cytology , Plant Shoots/growth & development , Plant Shoots/genetics , Plant Shoots/metabolism , Indoleacetic Acids/metabolism , Gene Expression Regulation, Plant , Phenotype , Homeodomain Proteins/metabolism , Homeodomain Proteins/genetics
3.
J Antimicrob Chemother ; 79(7): 1547-1554, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38727613

ABSTRACT

INTRODUCTION: Post-kala-azar dermal leishmaniasis (PKDL) arises as a dermal complication following a visceral leishmaniasis (VL) infection. Current treatment options for PKDL are unsatisfactory, and there is a knowledge gap regarding the distribution of antileishmanial compounds within human skin. The present study investigated the skin distribution of miltefosine in PKDL patients, with the aim to improve the understanding of the pharmacokinetics at the skin target site in PKDL. METHODS: Fifty-two PKDL patients underwent treatment with liposomal amphotericin B (20 mg/kg) plus miltefosine (allometric dosing) for 21 days. Plasma concentrations of miltefosine were measured on study days 8, 15, 22 and 30, while a punch skin biopsy was taken on day 22. A physiologically based pharmacokinetic (PBPK) model was developed to evaluate the distribution of miltefosine into the skin. RESULTS: Following the allometric weight-based dosing regimen, median miltefosine concentrations on day 22 were 43.73 µg/g (IQR: 21.94-60.65 µg/g) in skin and 33.29 µg/mL (IQR: 25.9-42.58 µg/mL) in plasma. The median individual concentration ratio of skin to plasma was 1.19 (IQR: 0.79-1.9). In 87% (45/52) of patients, skin exposure was above the suggested EC90 PK target of 10.6 mg/L associated with in vitro susceptibility. Simulations indicated that the residence time of miltefosine in the skin would be more than 2-fold longer than in plasma, estimated by a mean residence time of 604 versus 266 hours, respectively. CONCLUSION: This study provides the first accurate measurements of miltefosine penetration into the skin, demonstrating substantial exposure and prolonged retention of miltefosine within the skin. These findings support the use of miltefosine in cutaneous manifestations of leishmaniasis. In combination with parasitological and clinical data, these results are critical for the future optimization of combination therapies with miltefosine in the treatment of PKDL.


Subject(s)
Amphotericin B , Antiprotozoal Agents , Leishmaniasis, Cutaneous , Leishmaniasis, Visceral , Phosphorylcholine , Skin , Humans , Phosphorylcholine/analogs & derivatives , Phosphorylcholine/pharmacokinetics , Phosphorylcholine/administration & dosage , Phosphorylcholine/therapeutic use , Antiprotozoal Agents/pharmacokinetics , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/therapeutic use , Male , Adult , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/parasitology , Female , Skin/parasitology , Leishmaniasis, Visceral/drug therapy , Middle Aged , Young Adult , Amphotericin B/pharmacokinetics , Amphotericin B/therapeutic use , Amphotericin B/administration & dosage , Adolescent , Asia, Southern
4.
Article in English | MEDLINE | ID: mdl-38319780

ABSTRACT

In medical image processing, semantic segmentation plays an important role since, in most applications, it is required to find the exact location of the anomaly. It is tough than the segmentation or classification task since in this task class-belongingness of each pixel is predicted. The presence of noise, and variations of viewpoint, shape, and size of cells make it more challenging. In this work, two novel Atrous Convolution-based Deep Semantic Segmentation Networks: ACDSSNet-I, ACDSSNet-II are proposed for more accurate Sickle Cell Anemia (SCA) detection, which can mitigate these issues. The main contributions are: 1) Improvement of feature extraction performance by employing Atrous convolution-based dense prediction, which yields varying field-view with adaptive resolution; 2) Employment of Atrous spatial pyramid-based pooling resulting in more robust segmentation; 3) Upgrading the segmentation performance by adding an efficient decoder module to finetune the segmentation, particularly at object boundaries; 4) Design of modified DeepLabV3+ architectures (MDA) by introducing computationally efficient MobileNetV2 or ResNet50 as a base classifier; 5) Further performance improvement has been accomplished by hybridizing MDA-1 with MDA-2 by integrating the benefits of MobileNetV2 models and ADAM and SGDM optimizers; 6) Improvement of overall performance by efficiently utilizing the input image's saturation information only to minimize the false positive. Furthermore, the optimal selection of threshold value makes the hybridization of MDA-1 with MDA-2 efficient resulting in more accurate semantic segmentation. The experimental results illustrate the proposed model outperforms others with the best semantic segmentation performances: 98.21% accuracy, 99.00% specificity, and 0.9547 DSC value.

5.
Biochimie ; 220: 31-38, 2024 May.
Article in English | MEDLINE | ID: mdl-38123120

ABSTRACT

Despite the well-established role of macrophages in phagocytosing Leishmania, the contribution of the parasite to this process is not well understood. Present study provides insights into the mechanism underlying the MVK-induced entry of L. donovani and improve our knowledge of host-pathogen interactions. We have discussed Mevalonate kinase (MVK)-induced actin reorganization, modulation of signaling pathways and host cell functions. Our results show that LdMVK gains access to macrophage cytosol and induces actin assembly modulation through the activation of actin-related proteins: VASP, Src and ERM. We have also demonstrated that LdMVK induces Ca2+ signaling and Akt pathway in macrophages, which are critical components of Leishmania survival and proliferation. Interestingly, we found that antibodies against LdMVK can kill Leishmania-infected macrophages in culture by forming extracellular traps, highlighting the potential of LdMVK in inhibiting parasite death. Overall, LdMVK is a virulent factor in Leishmania that mediates parasite internalization and host modulation by targeting host proteins phosphorylation and calcium homeostasis having significant implications in disease progression.


Subject(s)
Actins , Leishmania donovani , Macrophages , Phagocytosis , Phosphotransferases (Alcohol Group Acceptor) , Actins/metabolism , Macrophages/parasitology , Macrophages/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Animals , Humans , Mice , Calcium Signaling
6.
Cytokine ; 173: 156435, 2024 01.
Article in English | MEDLINE | ID: mdl-37950929

ABSTRACT

The excessive production of IL-10, an anti-inflammatory cytokine, by Leishmania antigen-activated T cells is supposed to be a key player in the onset and progression of visceral leishmaniasis (VL). The IL-10-producing sources in VL remain unidentified and uncharacterized. In this study, we reveal that antigen-activated CD4+ T cells, i.e., CD44+CD4+ T cells expressing CD200R receptors, are the prime IL-10-producing phenotypes in Leishmania donovani infection-induced pathogenesis. These phenotypes are separate from CD25+Foxp3+CD4+ T regulatory cells, which are classical IL-10-producing phenotypes. In order to ascertain the role of CD200R and CD25 receptors in IL-10 overexpression-associated VL pathogenesis, we abrogated CD200R and CD25 receptor-mediated signaling in the infected mice. The splenic load of parasites and the size of the liver and spleen were significantly reduced in CD200-blocked mice as compared to CD25-blocked mice. Further, the CD200 blocking polarized CD4+ T cells to pro-inflammatory cytokines-producing phenotypes, as we observed a higher frequency of IFN-γ, TNF-α, and IL-12 positive cells as compared to controls including the CD25 blocking. Our findings suggest that in L. donovani infection-induced pathogenesis the expression of CD200R on antigen-activated T cells helps them to acquire IL-10-producing abilities as part of its one of the survival strategies. However, more studies would be warranted to better understand CD200R receptors role in VL pathogenesis and to develop the next generation of therapeutic and prophylactic control measures.


Subject(s)
Leishmania donovani , Leishmaniasis, Visceral , Animals , Mice , Interleukin-10/metabolism , Cytokines/metabolism , T-Lymphocytes, Regulatory , Phenotype
7.
Phys Med ; 114: 103138, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37914431

ABSTRACT

OBJECTIVE: Mammogram-based automatic breast cancer detection has a primary role in accurate cancer diagnosis and treatment planning to save valuable lives. Mammography is one basic yet efficient test for screening breast cancer. Very few comprehensive surveys have been presented to briefly analyze methods for detecting breast cancer with mammograms. In this article, our objective is to give an overview of recent advancements in machine learning (ML) and deep learning (DL)-based breast cancer detection systems. METHODS: We give a structured framework to categorize mammogram-based breast cancer detection techniques. Several publicly available mammogram databases and different performance measures are also mentioned. RESULTS: After deliberate investigation, we find most of the works classify breast tumors either as normal-abnormal or malignant-benign rather than classifying them into three classes. Furthermore, DL-based features are more significant than hand-crafted features. However, transfer learning is preferred over others as it yields better performance in small datasets, unlike classical DL techniques. SIGNIFICANCE AND CONCLUSION: In this article, we have made an attempt to give recent advancements in artificial intelligence (AI)-based breast cancer detection systems. Furthermore, a number of challenging issues and possible research directions are mentioned, which will help researchers in further scopes of research in this field.


Subject(s)
Breast Neoplasms , Deep Learning , Humans , Female , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Artificial Intelligence , Mammography/methods , Machine Learning
8.
Mol Immunol ; 163: 136-146, 2023 11.
Article in English | MEDLINE | ID: mdl-37778149

ABSTRACT

One of the major reasons behind the limited success of vaccine candidates against all forms of leishmaniasis is the inability of parasitic antigens to induce robust cell-mediated immunity and immunological memory. Here we find, for the first time, that the adjuvantation of whole-killed Leishmania vaccine (Leishvacc) with anti-CD200 and anti-CD300a antibodies enhances CD4+ T cells mediated immunity in vaccinated mice and provides protection against wild-type parasites. The antibody adjuvantation, either alone or with a TLR4 agonist monophosphoryl A (MPL-A), induced the production of pro-inflammatory cytokines viz., IFN-γ, TNF-α, and IL-2 by antigen experienced CD4+ T cells, and also enhanced their rate of conversion into their memory phenotypes against Leishvacc antigens. The antibody adjuvanted vaccine also promoted the generation of IgG2a-mediated protective humoral immunity in vaccinated mice. Further, the mice vaccinated with antibodies adjuvanted vaccine showed strong resilience against metacyclic forms of L. donovani parasites as we observed reduced clinical features such as splenomegaly, hepatomegaly, granulomatous tissues in the liver, and parasitic load in their spleen. The findings of this study demonstrate that the anti-CD200 and anti-CD300a antibodies have potential to increase the protective efficacy of the whole-killed Leishmania vaccine, and opens up a new gateway to diversify the roles of immune checkpoints in vaccine development against leishmaniasis.


Subject(s)
Leishmania donovani , Leishmania , Leishmaniasis Vaccines , Leishmaniasis, Visceral , Leishmaniasis , Parasites , Animals , Mice , Vaccines, Inactivated , Adjuvants, Immunologic/pharmacology , Leishmaniasis/prevention & control , Mice, Inbred BALB C , Antigens, Protozoan
9.
PLoS Negl Trop Dis ; 17(9): e0011200, 2023 09.
Article in English | MEDLINE | ID: mdl-37656745

ABSTRACT

BACKGROUND: The kala-azar elimination programme has resulted in a significant reduction in visceral leishmaniasis (VL) cases across the Indian Subcontinent. To detect any resurgence of transmission, a sensitive cost-effective surveillance system is required. Molecular xenomonitoring (MX), detection of pathogen DNA/RNA in vectors, provides a proxy of human infection in the lymphatic filariasis elimination programme. To determine whether MX can be used for VL surveillance in a low transmission setting, large numbers of the sand fly vector Phlebotomus argentipes are required. This study will determine the best method for capturing P. argentipes females for MX. METHODOLOGY/PRINCIPAL FINDINGS: The field study was performed in two programmatic and two non-programmatic villages in Bihar, India. A total of 48 households (12/village) were recruited. Centers for Disease Control and Prevention light traps (CDC-LTs) were compared with Improved Prokopack (PKP) and mechanical vacuum aspirators (MVA) using standardised methods. Four 12x12 Latin squares, 576 collections, were attempted (12/house, 144/village,192/method). Molecular analyses of collections were conducted to confirm identification of P. argentipes and to detect human and Leishmania DNA. Operational factors, such as time burden, acceptance to householders and RNA preservation, were also considered. A total of 562 collections (97.7%) were completed with 6,809 sand flies captured. Females comprised 49.0% of captures, of which 1,934 (57.9%) were identified as P. argentipes. CDC-LTs collected 4.04 times more P. argentipes females than MVA and 3.62 times more than PKP (p<0.0001 for each). Of 21,735 mosquitoes in the same collections, no significant differences between collection methods were observed. CDC-LTs took less time to install and collect than to perform aspirations and their greater yield compensated for increased sorting time. No significant differences in Leishmania RNA detection and quantitation between methods were observed in experimentally infected sand flies maintained in conditions simulating field conditions. CDC-LTs were favoured by householders. CONCLUSIONS/SIGNIFICANCE: CDC-LTs are the most useful collection tool of those tested for MX surveillance since they collected higher numbers of P. argentipes females without compromising mosquito captures or the preservation of RNA. However, capture rates are still low.


Subject(s)
Culicidae , Leishmaniasis, Visceral , Phlebotomus , Psychodidae , United States , Female , Humans , Animals , Male , Leishmaniasis, Visceral/epidemiology , Mosquito Vectors , RNA
12.
IEEE/ACM Trans Comput Biol Bioinform ; 20(3): 1817-1828, 2023.
Article in English | MEDLINE | ID: mdl-36318567

ABSTRACT

For the early diagnosis of hematological disorders like blood cancer, microscopic analysis of blood cells is very important. Traditional deep CNNs lead to overfitting when it receives small medical image datasets such as ALLIDB1, ALLIDB2, and ASH. This paper proposes a new and effective model for classifying and detecting Acute Lymphoblastic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) that delivers excellent performance in small medical datasets. Here, we have proposed a novel Orthogonal SoftMax Layer (OSL)-based Acute Leukemia detection model that consists of ResNet 18-based deep feature extraction followed by efficient OSL-based classification. Here, OSL is integrated with the ResNet18 to improve the classification performance by making the weight vectors orthogonal to each other. Hence, it integrates ResNet benefits (residual learning and identity mapping) with the benefits of OSL-based classification (improvement of feature discrimination capability and computational efficiency). Furthermore, we have introduced extra dropout and ReLu layers in the architecture to achieve a faster network with enhanced performance. The performance verification is performed on standard ALLIDB1, ALLIDB2, and C_NMC_2019 datasets for efficient ALL detection and ASH dataset for effective AML detection. The experimental performance demonstrates the superiority of the proposed model over other compairing models.


Subject(s)
Leukemia, Myeloid, Acute , Humans , Leukemia, Myeloid, Acute/diagnosis , Leukemia, Myeloid, Acute/genetics , Machine Learning
14.
J Acquir Immune Defic Syndr ; 91(3): 319-324, 2022 11 01.
Article in English | MEDLINE | ID: mdl-35916635

ABSTRACT

BACKGROUND: To evaluate the prevalence and correlates of concurrent uterine cervical and anal HR-HPV infections in women living with HIV (WLHIV). SETTING: A cross-sectional study was undertaken at a tertiary care hospital and linked ART center. METHODS: One hundred and forty-one WLHIV and 161 HIV-negative women were enrolled for cervical and anal cytology as well as HR-HPV testing using the HC2 method. Screen-positive women were followed-up with colposcopy/anoscopy and/or repeat cytology. Appropriate statistical tests were applied to assess the association of concurrent HR-HPV with various parameters. RESULTS: Concurrent cervical and anal HR-HPV infection was detected in 22 WLHIV (16.3%) and 5 HIV-negative women (3.1%), the difference being statistically significant ( P < 0.001 ). Among WLHIV, concurrent HR-HPV was associated with tobacco use ( P < 0.001 ), receptive anal intercourse ( P = 0.02 ), low CD4 counts ( P = 0.001 ), and negatively with ART intake ( P = 0.004 ) on bivariate analysis. Multivariate logistic regression analysis showed a positive association of concurrent HR-HPV positivity with tobacco use ( P = 0.02 ) and low nadir CD4 counts ( P = 0.03 ). CONCLUSIONS: WLHIV, especially those with CD4 counts less than 200/µL, should be offered HR-HPV screening and follow-up to detect cervical and anal lesions.


Subject(s)
Anus Diseases , HIV Infections , Papillomavirus Infections , Uterine Cervical Neoplasms , Anus Diseases/complications , Anus Diseases/epidemiology , Cross-Sectional Studies , Female , HIV Infections/epidemiology , Humans , Papillomaviridae , Papillomavirus Infections/complications , Papillomavirus Infections/epidemiology , Prevalence , Uterine Cervical Neoplasms/epidemiology
16.
Sci Rep ; 12(1): 14436, 2022 08 24.
Article in English | MEDLINE | ID: mdl-36002553

ABSTRACT

Kala-azar/Visceral Leishmaniasis (VL) caused by Leishmania donovani (LD) is often associated with Leptomonas seymouri (LS) co-infection in India. Leptomonas seymouri narna-like virus 1 (Lepsey NLV1) has been reported in multi-passaged laboratory isolates of VL samples which showed LD-LS co-infection. A pertinent question was whether this virus of LS is detectable in direct clinical samples. DNA from the serum of twenty-eight LD diagnosed patients was subjected to LD-specific and LS-specific PCR to reconfirm the presence of LD parasites and to detect LD-LS co-infections. RNA extracted from same samples was subjected to RT-PCR, qRT-PCR and sequencing using virus-specific primers to detect/identify and quantify the virus. The presence of the virus was confirmed in thirteen of eighteen (72%) recently collected VL and PKDL samples. Cytokine profiling showed significantly elevated IL-18 in only LD infected patients compared to the virus-positive LD and control samples. IL-18 is crucial for Th1 and macrophage activation which eventually clears the parasite. The Lepsey NLV1 interaction with the immune system results in reduced IL-18 which favors LD survival and increased parasitic burden. The study emphasizes the need to revisit LD pathogenesis in the light of the association and persistence of a protozoan virus in kala-azar and PKDL patients.


Subject(s)
Coinfection , Leishmania donovani , Leishmaniasis, Cutaneous , Leishmaniasis, Visceral , Trypanosomatina , Coinfection/diagnosis , Humans , India , Interleukin-18 , Leishmania donovani/genetics , Leishmaniasis, Visceral/parasitology , Trypanosomatina/genetics
19.
Epidemics ; 39: 100562, 2022 06.
Article in English | MEDLINE | ID: mdl-35561500

ABSTRACT

Visceral leishmaniasis (VL) is declining in India and the World Health Organization's (WHO) 2020 'elimination as a public health problem' target has nearly been achieved. Intensified combined interventions might help reach elimination, but their impact has not been assessed. WHO's Neglected Tropical Diseases 2021-2030 roadmap provides an opportunity to revisit VL control strategies. We estimated the combined effect of a district-wide pilot of intensified interventions in the highly-endemic Vaishali district, where cases fell from 3,598 in 2012-2014 to 762 in 2015-2017. The intensified control approach comprised indoor residual spraying with improved supervision; VL-specific training for accredited social health activists to reduce onset-to-diagnosis time; and increased Information Education & Communication activities in the community. We compared the rate of incidence decrease in Vaishali to other districts in Bihar state via an interrupted time series analysis with a spatiotemporal model informed by previous VL epidemiological estimates. Changes in Vaishali's rank among Bihar's endemic districts in terms of monthly incidence showed a change pre-pilot (3rd highest out of 33 reporting districts) vs. during the pilot (9th) (p<1e-10). The rate of decline in Vaishali's incidence saw no change in rank at 11th highest, both pre-pilot & during the pilot. Counterfactual model simulations suggest an estimated median of 352 cases (IQR 234-477) were averted by the Vaishali pilot between January 2015 and December 2017, which was robust to modest changes in the onset-to-diagnosis distribution. Strengthening control strategies may have precipitated a substantial change in VL incidence in Vaishali and suggests this approach should be piloted in other highly-endemic districts.


Subject(s)
Leishmaniasis, Visceral , Humans , Incidence , India/epidemiology , Interrupted Time Series Analysis , Leishmaniasis, Visceral/epidemiology , Leishmaniasis, Visceral/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL